Seeing in Numbers

By Arup K. Chakraborty Seeing in Numbers How concepts from physics and engineering are informing questions about T cell selection and antigen recognition. In the fall of 1999, a colleague at Berkeley, Graham Fleming, invited me to lunch with a newly arrived postdoc who was exploring immunology—a new field for him. My research couldn’t have been less related: theoretical problems in polymer physics and catalytic materials. But, one of Graha

Written byArup K. Chakraborty
| 12 min read

Register for free to listen to this article
Listen with Speechify
0:00
12:00
Share

In the fall of 1999, a colleague at Berkeley, Graham Fleming, invited me to lunch with a newly arrived postdoc who was exploring immunology—a new field for him. My research couldn’t have been less related: theoretical problems in polymer physics and catalytic materials. But, one of Graham’s roles was to facilitate interaction between the physical sciences and biology. At 37, I was comfortably ensconced at Berkeley as a tenured full professor, and having no research interest in biology, I went along with a certain measure of skepticism.

The postdoc, Jay Groves, brought with him a paper about the immunological synapse, which is the structured zone of spatially patterned receptors and ligands that forms between a lymphocyte and an antigen-presenting cell (APC) bearing molecular signatures of pathogens. While immunologists previously had x-ray crystallography images showing how some of these proteins interacted individually, this paper visualized how multiple receptors interacted at the ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies